Polyorbit Pvt Ltd is developing India’s first exosome-based bone graft and filler for bone regeneration. The non-cellular, off-the-shelf technology uses bioactive exosomes from osteoblasts or dental pulp stem cells to stimulate bone healing, angiogenesis, and immune modulation. It offers a safer, biologically active alternative to autografts, allografts, and inert ceramics. Backed by global research, the platform aims to deliver a scalable, GMP-compliant, and cost-effective solution for orthopedic and dental care across India.